tiprankstipranks
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
US Market
ANIP
ANI Pharmaceuticals
RESEARCH TOOLSreports

ANI Pharmaceuticals (ANIP) Income Statement

Compare
354 Followers

ANI Pharmaceuticals Income Statement

Last quarter (Q4 2025), ANI Pharmaceuticals's total revenue was $247.06M, an increase of 29.64% from the same quarter last year. In Q4, ANI Pharmaceuticals's net income was $27.49M. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 883.37M$ 614.38M$ 486.82M$ 316.38M$ 216.14M
Gross Profit
$ 450.64M$ 364.17M$ 305.30M$ 177.60M$ 115.53M
Operating Expenses
$ 369.41M$ 363.58M$ 258.33M$ 212.88M$ 155.32M
Depreciation and Amortization
$ 91.42M$ 67.73M$ 59.79M$ 59.65M$ 47.25M
EBITDA
$ 207.27M$ 63.12M$ 106.60M$ 25.04M$ 3.12M
Operating Income
$ 81.23M$ 584.00K$ 46.97M$ -35.28M$ -39.79M
Other Income/Expenses
$ 14.56M$ -22.80M$ -27.10M$ -27.38M$ -16.27M
Pretax Income
$ 95.79M$ -22.21M$ 19.87M$ -62.66M$ -56.06M
Net Income
$ 78.34M$ -18.52M$ 18.78M$ -47.90M$ -42.60M
Per Share Metrics
Basic EPS
$ 3.50$ -1.04$ 0.95$ -3.05$ -3.40
Diluted EPS
$ 3.32$ -1.04$ 0.94$ -3.05$ -3.40
Weighted Average Shares Outstanding
 20.05M 19.32M 18.00M 16.26M 12.60M
Weighted Average Shares Outstanding (Diluted)
 21.23M 19.32M 18.19M 16.26M 12.60M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History